ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Altareit

Altareit (AREIT)

478.00
0.00
( 0.00% )
Actualizado: 02:00:18

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
478.00
Postura de Compra
476.00
Postura de Venta
482.00
Volume Operado de la Acción
1
478.00 Rango del Día 478.00
440.00 Rango de 52 semanas 480.00
Capitalización de Mercado [m]
Precio Anterior
478.00
Precio de Apertura
478.00
Última hora de negociación
02:00:18
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
1
Acciones en circulación
1,748,404
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.57
Beneficio por acción (BPA)
-186.23
turnover
2.45B
Beneficio neto
-325.6M

Acerca de Altareit

Sector
Operators-apartment Bldgs
Industria
Operators-apartment Bldgs
Sitio web
Sede
Paris, Paris, Fra
Fundado
-
Altareit is listed in the Operators-apartment Bldgs sector of the Euronext with ticker AREIT. The last closing price for Altareit was 478.00 €. Over the last year, Altareit shares have traded in a share price range of 440.00 € to 480.00 €.

Altareit currently has 1,748,404 shares in issue. The market capitalisation of Altareit is 835.74 € million. Altareit has a price to earnings ratio (PE ratio) of -2.57.

AREIT Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1004784784781478DE
481.702127659574704784701475.89473684DE
12102.136752136754684784681471.25DE
26286.222222222224504784501463.08571429DE
52245.286343612334544804402458.99755501DE
156-177-27.02290076346557004202533.24140212DE
260-82-14.64285714295607204202539.2360515DE

AREIT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Altareit?
El precio actual de las acciones de Altareit es 478.00 €
¿Cuántas acciones de Altareit están en circulación?
Altareit tiene 1,748,404 acciones en circulación
¿Cuál es la capitalización de mercado de Altareit?
La capitalización de mercado de Altareit es EUR 835.74M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Altareit?
Altareit ha negociado en un rango de 440.00 € a 480.00 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Altareit?
El ratio precio/beneficio de Altareit es -2.57
¿Cuál es el ratio de efectivo a ventas de Altareit?
El ratio de efectivo a ventas de Altareit es 0.34
¿Cuál es la moneda de reporte de Altareit?
Altareit presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Altareit?
El último ingresos anual de Altareit es EUR 2.45B
¿Cuál es el último beneficio anual de Altareit?
El último beneficio anual de Altareit es EUR -325.6M
¿Cuál es la dirección registrada de Altareit?
La dirección registrada de Altareit es 87 RUE DE RICHELIEU, PARIS, PARIS, 75002
¿Cuál es la dirección del sitio web de Altareit?
La dirección del sitio web de Altareit es www.altareit.com
¿En qué sector industrial opera Altareit?
Altareit opera en el sector OPERATORS-APARTMENT BLDGS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALMASMastrad
0.024 €
(18.81%)
2.15M
ALNEVNeovacs
0.4389 €
(12.45%)
3.13k
SEQUASequana medical NV
2.63 €
(10.50%)
59.05k
ALMIBAmoeba
0.995 €
(10.07%)
400.43k
KERKering
266.85 €
(7.95%)
131.05k
DMSBSDiagnostic Medical Systems
0.0045 €
(-35.71%)
80
GNROGeNeuro SA
0.182 €
(-18.75%)
122.28k
ALBOOBOOSTHEAT
0.0566 €
(-17.97%)
1.3k
ALMDTMedian Technologies
3.87 €
(-17.48%)
120.94k
ALBIOBiosynex
1.414 €
(-15.43%)
2.62k
ATOAtos SE
0.0022 €
(4.76%)
42.25M
ALCYBCybergun
0.0001 €
(0.00%)
11.14M
ALVERVergnet
0.0015 €
(7.14%)
9.41M
BCPBanco Comercial Portugues SA
0.516 €
(-0.50%)
8.54M
BIOSBiosenic
0.0046 €
(-8.00%)
2.84M
Seminole Red Seminole Red 4 minutos hace
Unusually windy conditions dominated Thursday’s second round at Torrey Pines. Gusts of 30 mph wreaked havoc on the field, with the only reprieve being the 90 minutes that play was delayed due to extreme conditions. Only 11 players had shot under-par rounds when play was suspended due to darkness. Bo
SteveSchiets SteveSchiets 10 minutos hace
Still you guys are here? Is that Future fault?

I'm here for the upswing, if that ever happens.
SEV
walterc walterc 10 minutos hace
well done
thank you
GCUMF
ofirm ofirm 12 minutos hace
Nexpoint knows more about what is the hidden value here than almost anyone else. would not be surprised as well.
joeycav11 joeycav11 14 minutos hace
Heres an announcement I would love to hear…
On the back of approval for dcvax for glioblastoma in Britain we are expanding our pay for compassionate care clinical trials to include breast lung and colon cancers. The cost will be 250,000 usd
Paying patients will be automatically includ
NWBO
demonsmith demonsmith 15 minutos hace
Nothing it will be halted for couple months
TWOH
demonsmith demonsmith 16 minutos hace
It going to be while before halt lifted there nothing anyone can do or say up to sce and company
TWOH
AlwaysOptimistic AlwaysOptimistic 17 minutos hace
Totally agree ge. I also think NE's State electors could do a better job advocating for NioCorp Federal assistance. We now have Republican elected Senators/=, Congressmen and Governor and a Republican dominated Senate, Congress and President.

It's not just NioCorp that needs to put he
NB
pinkslipjunkie pinkslipjunkie 19 minutos hace
I seen that earlier today and all I can say is it at least tells us that they are active and it sounds like they plan to pump it one way or another...they were doing a good job staying current until 3rd quarter 2024...that filing would be a start.
PDGO
thistraderknowsall thistraderknowsall 23 minutos hace
MAJOR BREAKOUT!**** SPELL**** Crypto!!! AI!!
Nice move up! And now SPELL exponentially moving up to $1 also!!

CONGRATS!!
Guido2 Guido2 33 minutos hace
I believe AlphaSpread is located in Hong Kong. It could be their way of writing. I’m vacationing in India and noticed 100,000 is written as 1,00,000. They call a hundred thousand a lakh. 10 million is called a crore.
FNMA
DruidOracle55 DruidOracle55 36 minutos hace
I had a vision one day and it said i would be 10x richer than Musk in 5 years.
IQST
DruidOracle55 DruidOracle55 37 minutos hace
What is their NET income for 2024? lets see how many people know what they invest in
IQST
Here Today Here Today 39 minutos hace
Seems like someone is attempting to wrestle away control of the company via majority ownership of the shares. That and there is between 12 - 14 % of total OS shorted that is being reported and not including any of the "Dark Pool - Never Covered" Shorted shares.
RNAZ
DruidOracle55 DruidOracle55 39 minutos hace
P&D in action-so predictable.
UMAV
DruidOracle55 DruidOracle55 41 minutos hace
So more BS
AXXA
DruidOracle55 DruidOracle55 43 minutos hace
Jason is just as real as James Bond
AXXA
DruidOracle55 DruidOracle55 44 minutos hace
Who is Jason?
AXXA
joeycav11 joeycav11 49 minutos hace
I think the reason to keep reiterating stock goes to a buck on mhra approval is to condition shareholders to sell if it opens at 2.50 Make them feel like they should consider taking some money off the table.
NWBO
bbotcs bbotcs 55 minutos hace
A third term for President Trump? https://www.yahoo.com/news/tennessee-republican-proposes-amendment-allow-000727320.html
bbotcs bbotcs 58 minutos hace
Gmenfan: That would be great. So would using more ngas!
bbotcs bbotcs 60 minutos hace
lj: oil
Trump wants cheap oil. Heard on TV tonight, right or wrong I don't know, that they would have to get the oil price down to $45 a barrel to force Russia's economy into major trouble. Stranger things have happened.
It is obvious that Trump is seeking cooperation from the Saudi
Investor2014 Investor2014 60 minutos hace
Highly inappropriate, unscientific and unfortunate, but fits the uniformity of the P2b/3 trial population and so for that reason may not be requiring further trials. I can see that would likely also be a fit with much of the poster population.

https://x.com/adamfeuerstein/status/18825
AVXL

Su Consulta Reciente

Delayed Upgrade Clock